<DOC>
	<DOCNO>NCT01379742</DOCNO>
	<brief_summary>This study investigate health relate quality life factor patient undergo low dose rate prostate brachytherapy . Patients randomize Iodine-125 Thinstrand ( use 20 g needle ) Rapidstrand ( use standard 18 g needle ) . Urinary , bowel , sexual function bother measure EPIC questionnaire various time interval .</brief_summary>
	<brief_title>Comparison Between ThinSeed™ OncoSeed™ Permanent Prostate Brachytherapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically confirm adenocarcinoma prostate , clinical stage T1c T2b , N0 , M0 Greater equal 40 year age Low Low Intermediate Risk prostate cancer Prostate volume TRUS ≤ 60 cc IPSS score &lt; 25 ( alpha blocker allow ) Signed studyspecific inform consent form prior study entry Lymph node involvement ( N1 ) Evidence distant metastasis ( M1 ) Radical surgery carcinoma prostate Prior pelvic radiation Major medical psychiatric illness , investigator 's opinion would prevent completion treatment would interfere follow ability complete questionnaire Hip prosthesis Inability refusal provide inform consent Evidence Previous TURP Prior hormone therapy Prior TURP</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>prostate brachytherapy</keyword>
</DOC>